β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
Hepatocellular cancer (HCC), the most common primary liver tumor, has been gradually growing in incidence globally. The whole-genome and whole-exome sequencing of HCC has led to an improved understanding of the molecular drivers of this tumor type. Activation of the Wnt signaling pathway, mostly due...
Main Authors: | Yekaterina Krutsenko, Aatur D. Singhi, Satdarshan P. Monga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1830 |
Similar Items
-
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
by: Tomoko Aoki, et al.
Published: (2023-10-01) -
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
by: Xi-Feng Jin, et al.
Published: (2020-02-01) -
β-catenin inhibitors in cancer therapeutics: intricacies and way forward
by: Arundhathi Dev, et al.
Published: (2023-12-01) -
siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
by: Gang Zeng, et al.
Published: (2007-11-01) -
Mechanisms of mutant β-catenin in endometrial cancer progression
by: Molly L. Parrish, et al.
Published: (2022-09-01)